Open AccessCardiac dysfunction and prenatal exposure to venlafaxine
Author(s) -
Araújo Ana R,
Marçal Mónica,
Tuna Madalena,
Anjos Rui
Publication year - 2016
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.412
Subject(s) - medicine , venlafaxine , cardiac dysfunction , antidepressant , in utero , cardiology , anesthesia , pregnancy , fetus , heart failure , genetics , biology , hippocampus
Key Clinical Message Venlofaxine, a widely used antidepressant, is known to cause a withdrawal syndrome. We present a case of neonatal transient ventricular dysfunction in a neonate exposed to venlafaxine in utero. Other causes of ventricular dysfunction were excluded. Neonatal ventricular dysfunction can be a possible side effect of maternal use of this drug.